Anthony N. DeMaria, MD, MACC

General Statement of Disclosure:

SPEAKER'S BUREAU: Zoll Pharmaceutical (SIGNIFICANT), Bracco(MODEST) RESEARCH/RESEARCH GRANTS: Bracco (SIGNIFICANT), Trust(SIGNIFICANT) OTHER FINANCIAL BENEFIT: ResMed Foundation(MODEST), Hitachi Inc(NONE)

View Full Disclosure